Renovia Incorporated is a company that was started up back in 2016. This company was co founded by a former executive in the healthcare industry named Marc Beer. Recently, Marc Beer helped raise $42 million to help start up Renovia. In order to get the funding, Beer closed a $32 million Series B financing arrangement as well as taking on an additional $10 million in venture capital funding. With the establishment of Renovia, Marc will have a company that will specialize in diagnosing and treating a number of pelvic floor disorders. The company will also provide therapy products and diagnostic technology to help treat a variety of conditions that include urinary incontinence. With the development of these products and technologies, Renovia will be in position to help treat over 200 million women worldwide who have various pelvic floor disorders. In another recent announcement, Renovia introduced its first product known as Leva which was approved by the federal Food and Drug Administration last April.
In order to complete the deal to secure funding for Renovia, Marc Beer used an entity called the Longwood Fund. The Longwood Fund was used to secure Series B funding for the company. Along with using the Longwood Fund, Renovia and Marc Beer worked with Perceptive Advisors and Ascension Ventures to finalize the funding to establish Renovia. The funding will enable the company and other financing entities to collaborate in developing effective treatments for pelvic floor disorders. The new product line that Renovia will look to develop in the future that include four new products that will diagnose, treat and provide therapy for pelvic floor disorders. There is also going to be a a new Leva product introduced in the near future as well.
After securing the funding for the new company, Marc Beer expressed a lot of satisfaction. He was thrilled that the company has been able to get the capital and financing it needed in order to start up as well as improve its product line. As well as getting the funding for the company and new product lines, Renovia is also going to come up with technology that will allow it to better inform customers. Whenever a customer uses the company’s products, Renovia will be able to get feedback so that they can find more effective treatments for pelvic floor disorders. This will result in more innovation and better ways to help people restore their health. Learn more: https://people.equilar.com/bio/marc-beer-aegerion-pharmaceuticals-/salary/78453
Marc Beer is a longtime executive in the biotechnology and pharmaceutical industries. He has over 25 years of experience in these fields. As a top executive in these industries, he has been able to gather lots of knowledge and develop expertise on how to more innovations in the healthcare industry. These innovations include more effective drug and therapy treatments as well as technology to help people improve their health. As of today Marc Beer is the chief executive officer of Renovia along with serving as both its chairman and chief executive officer. He has held these positions since starting the company in 2016.